These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33239)

  • 1. Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations.
    Mullen PW; Foster RW
    J Pharm Pharmacol; 1979 Feb; 31(2):100-4. PubMed ID: 33239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal phenytoin therapy: a new technique for individualizing dosage.
    Mullen PW
    Clin Pharmacol Ther; 1978 Feb; 23(2):228-32. PubMed ID: 620485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin pharmacokinetic analysis and steady-state level prediction using a programmable calculator.
    Ng PK
    Int J Biomed Comput; 1980 Jul; 11(4):329-034. PubMed ID: 7399737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualizing phenytoin dosage regimens using a programmable calculator.
    Ng PK
    Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.
    Popović J
    Eur J Drug Metab Pharmacokinet; 2004; 29(3):205-14. PubMed ID: 15537173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of methods for the prediction of phenytoin concentrations.
    Vázquez Rodríguez A; Santos Buelga D; Alonso González AC; Garcćia Sánchez MJ; Domínguez-Gil Hurlé A
    J Clin Pharm Ther; 1991 Feb; 16(1):55-62. PubMed ID: 2026669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
    Nakashima E; Matsushita R; Kido H; Nakamura M; Asahi M; Ichimura F
    Ther Drug Monit; 1995 Feb; 17(1):12-8. PubMed ID: 7725371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interindividual variation in the extent and rate of phenytoin accumulation.
    Levine M; Orr J; Chang T
    Ther Drug Monit; 1987 Jun; 9(2):171-6. PubMed ID: 3617156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precautions in the use of Michaelis-Menten kinetics in the prediction of phenytoin levels.
    Jochsberger T
    Drug Intell Clin Pharm; 1986; 20(7-8):605-6. PubMed ID: 3743419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T; Coleman R; Ludden T; Peck CC; Rose D
    Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steady state population kinetics of intravenous phenytoin.
    Frame B; Beal SL
    Ther Drug Monit; 1998 Aug; 20(4):408-16. PubMed ID: 9712466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.
    Chrystyn H; Morgan DH
    J Clin Hosp Pharm; 1986 Dec; 11(6):443-8. PubMed ID: 3818966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a nomogram for estimating the rate of phenytoin accumulation.
    Levine M; Orr J; Chang T
    Ther Drug Monit; 1987 Jun; 9(2):166-70. PubMed ID: 3617155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of population pharmacokinetic parameters of phenytoin using the parallel Michaelis-Menten and first-order elimination model.
    Valodia PN; Seymour MA; McFadyen ML; Miller R; Folb PI
    Ther Drug Monit; 2000 Jun; 22(3):313-9. PubMed ID: 10850399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin age-dose-concentration relationship in children.
    Suzuki Y; Mimaki T; Cox S; Koepke J; Hayes J; Walson PD
    Ther Drug Monit; 1994 Apr; 16(2):145-50. PubMed ID: 8009561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of phenytoin in South African black patients.
    Miller R; Rheeders M; Klein C; Suchet I
    S Afr Med J; 1987 Aug; 72(3):188-90. PubMed ID: 3603312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the pharmacokinetic techniques available for individualizing phenytoin dosage.
    Messori A; Zaccara G; Valenza T; Arnetoli G; Bartoli C; Donati-Cori G; Muscas GC; Tendi E
    J Clin Hosp Pharm; 1983 Dec; 8(4):357-65. PubMed ID: 6689330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin dosage individualization--five methods compared in the elderly.
    Hudson SA; Farquhar DL; Thompson D; Smith RG
    J Clin Pharm Ther; 1990 Feb; 15(1):25-34. PubMed ID: 2318914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.